Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
Clinical trial NCT05630001 · COMPLETED
Trial details
- NCT number
- NCT05630001
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2024-10-17
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.